Hereditary genetic diseases, cancer, and infectious diseases are affecting global health and
become major health issues, but the treatment development remains challenging. Gene …

Treatment options for retinal diseases, such as neovascular age-related macular
degeneration, diabetic retinopathy, and retinal vascular disorders, have markedly expanded …

DNA encodes the genetic information; recently, it has also become a key player in material
science. Given the specific Watson–Crick base‐pairing interactions between only four types …

Recent efforts in designing nanomaterials to deliver potential therapeutics to the targeted
site are overwhelming and palpable. Engineering nanomaterials to deliver biological …

Detection and treatment of lung cancer still remain a clinical challenge. This study aims to
validate exosomal microRNA‐96 (miR‐96) as a serum biomarker for lung cancer and …

Despite being the most prevalent cause of inherited blindness in children, Stargardt disease
is yet to achieve the same clinical trial success as has been achieved for other inherited …

To improve the ocular bioavailability of the strongly hydrophilic moxifloxacin hydrochloride,
hyaluronic-acid-modified lipid-polymer hybrid nanoparticles (HA-LCS-NPs) were designed …

Stargardt disease (STGD) is the most common form of inherited retinal genetic disorders and
is often caused by mutations in ABCA4. Gene therapy has the promise to effectively treat …

Retinal diseases, such as age-related macular degeneration and diabetic retinopathy, are
the leading causes of blindness worldwide. The mainstay of treatment for these blinding …

The ocular delivery of drugs encounters several limitations because of the dynamic and
static barriers of the human's eye anatomy and physiology. The poor bioavailability of drugs …